HERON THERAPEUTICS, INC. /DE/ Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Heron Therapeutics, Inc. /De/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 153M shares, a 5.41% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 138M shares, a 26.9% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 109M shares, a 10.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 153M +7.84M +5.41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 152M +32.6M +27.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 151M +32M +26.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 138M +29.3M +26.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 145M +33.3M +29.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 120M +17.3M +16.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 119M +17.1M +16.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 109M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 112M +9.83M +9.65% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 102M +3.95M +4.01% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 102M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 102M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 98.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.